Oncology Books

2618 products


  • Benzene

    IARC Benzene

    5 in stock

    Book Synopsis

    5 in stock

    £42.00

  • International Agency for Research on Cancer International Agency for Research on Cancer:

    Out of stock

    Book Synopsis

    Out of stock

    £30.51

  • 2 in stock

    £28.90

  • International Agency for Research on Cancer International Agency for Research on Cancer

    5 in stock

    Book Synopsis

    5 in stock

    £29.10

  • Out of stock

    £55.18

  • International Agency for Research on Cancer Carbon Black: Iarc Monographs on the Evaluation

    2 in stock

    Book Synopsis

    2 in stock

    £55.00

  • International Agency for Research on Cancer Combined Estrogen-progestogen Contraceptives and

    Out of stock

    Book Synopsis

    Out of stock

    £59.38

  • International Agency for Research on Cancer Household Use of Solid Fuels and High Temperature

    2 in stock

    Book Synopsis

    2 in stock

    £54.15

  • International Agency for Research on Cancer Consumption of Alcoholic Beverages and Ethyl

    Out of stock

    Book Synopsis

    Out of stock

    £60.50

  • International Agency for Research on Cancer Painting, Firefighting and Shiftwork

    Out of stock

    Book Synopsis

    Out of stock

    £54.15

  • International Agency for Research on Cancer Butadiene, Ethylene Oxide and Vinyl Halides

    3 in stock

    Book Synopsis

    3 in stock

    £58.43

  • IARC Directory of agents being tested for

    Out of stock

    Book Synopsis

    Out of stock

    £52.20

  • International Agency for Research on Cancer A review of human carcinogens: D: Radiation

    1 in stock

    Book Synopsis

    1 in stock

    £58.77

  • Non-ionizing radiation: Part 2, Radiofrequency

    International Agency for Research on Cancer Non-ionizing radiation: Part 2, Radiofrequency

    4 in stock

    Book Synopsis

    4 in stock

    £59.74

  • Bitumens and bitumen emissions, and some N- and

    International Agency for Research on Cancer Bitumens and bitumen emissions, and some N- and

    3 in stock

    Book Synopsis

    3 in stock

    £58.64

  • World Health Organization Biomarkers in Cancer Chemoprevention

    2 in stock

    Book Synopsis

    2 in stock

    £39.58

  • International Agency for Research on Cancer Nutrition and Lifestyle: Opportunities for Cancer

    2 in stock

    Book Synopsis

    2 in stock

    £61.50

  • Atlas of Cancer Mortality in European Union and

    International Agency for Research on Cancer Atlas of Cancer Mortality in European Union and

    3 in stock

    Book Synopsis

    3 in stock

    £30.70

  • Cancer Incidence in Five Continents: v. 9

    International Agency for Research on Cancer Cancer Incidence in Five Continents: v. 9

    7 in stock

    Book Synopsis

    7 in stock

    £246.81

  • Out of stock

    £133.00

  • World Health Organization Cancer Incidence in Five Continents

    Out of stock

    Book Synopsis

    Out of stock

    £225.00

  • World Health Organization Exposure to Artificial UV Radiation and Skin

    Out of stock

    Book Synopsis

    Out of stock

    £27.14

  • Code of Good Scientific Practice: v. 4: IARC

    International Agency for Research on Cancer Code of Good Scientific Practice: v. 4: IARC

    7 in stock

    Book Synopsis

    7 in stock

    £16.34

  • International Agency for Research on Cancer Retinoids: Iarc Handbooks of Cancer Prevention

    Out of stock

    Book Synopsis

    Out of stock

    £79.11

  • International Agency for Research on Cancer Non-Steroidal Anti-Inflammatory Drugs: Iarc

    Out of stock

    Book Synopsis

    Out of stock

    £46.42

  • International Agency for Research on Cancer Carotenoids: IARC Handbooks of Cancer Prevention

    Out of stock

    Book Synopsis

    Out of stock

    £47.01

  • Fruit and Vegetables

    International Agency for Research on Cancer Fruit and Vegetables

    2 in stock

    Book Synopsis

    2 in stock

    £49.16

  • International Agency for Research on Cancer Sunscreens: IARC Handbook on Cancer Prevention:

    Out of stock

    Book Synopsis

    Out of stock

    £46.72

  • WHO Classification of Breast Tumours: WHO

    £152.00

  • WHO classification of female genital tumours

    £169.73

  • WHO classification of tumours of the central

    £150.21

  • WHO reporting system for Pancreaticobiliary

    £84.28

  • WHO Reporting System for Lung Cytopathology

    £83.10

  • My Personal Experience with Breast Cancer

    WHO Regional Office for the Eastern Mediterranean My Personal Experience with Breast Cancer

    4 in stock

    Book Synopsis

    4 in stock

    £14.48

  • Manual on the Prevention and Control of Common

    World Health Organization Manual on the Prevention and Control of Common

    Out of stock

    Book Synopsis

    Out of stock

    £999.99

  • Jaypee Brothers Medical Publishers Handbook of Radiobiology

    Out of stock

    Book SynopsisRadiobiology, also known as radiation biology, is a field of clinical and basic medical sciences that involves the study of the action of ionising radiation on living things. This handbook is a complete guide to radiobiology for postgraduate students. Beginning with an overview of human biology and radiation physics, the following chapters explain the interaction of radiation with cells, its beneficial damage to cancer cells, and adverse effects on normal cells and organs. The final sections of the book cover time, dose and fractionation models, and radiation safety and protection. Enhanced by images and tables, this useful reference text is presented in a logical format with simple terms to assist learning and understanding. Key Points Complete guide to radiobiology for postgraduate students Covers beneficial damage to cancer cells and adverse effects on normal cells Explains time, dose and fractionation models Logical, easy to understand format Table of Contents Human Biology Radiation Physics Interaction of Radiation with Cell Cell Survival Curves Modification of Cell Survival Biological Effects of Radiation Normal Tissue Reactions of Radiation Biological Basis of External Beam Radiotherapy Biological Basis of Brachytherapy Time, Dose and Fractionation Models Radiation Safety and Protection Index

    Out of stock

    £999.99

  • Oncothermia: Principles and Practices

    Springer Oncothermia: Principles and Practices

    1 in stock

    Book SynopsisOncothermia is the next generation medical innovation that delivers selective, controlled and deep energy for cancer treatment. The basic principles for oncothermia stem from oncological hyperthermia, the oldest approach to treating cancer. Nevertheless, hyperthermia has been wrought with significant controversy, mostly stemming from shortcomings of controlled energy delivery. Oncothermia has been able to overcome these insufficiencies and prove to be a controlled, safe and efficacious treatment option. This book is the first attempt to elucidate the theory and practice of oncothermia, based on rigorous mathematical and biophysical analysis, not centered on the temperature increase. It is supported by numerous in-vitro and in-vivo findings and twenty years of clinical experience. This book will help scientists, researchers and medical practitioners in understanding the scientific and conceptual underpinnings of oncothermia and will add another valuable tool in the fight against cancer. Professor Andras Szasz is the inventor of oncothermia and the Head of St Istvan University's Biotechnics Department in Hungary. He has published over 300 papers and lectured at various universities around the world. Dr. Oliver Szasz is the managing director of Oncotherm, the global manufacturer and distributor of medical devices for cancer treatment used in Europe & Asia since the late 1980s. Dr. Nora Szasz is currently a management consultant in healthcare for McKinsey & Co. Table of ContentsOBJECTIVE OF THE BOOK 1. ONCOLOGY – TREATMENTS AND THEIR LIMITS 1.1. CANCER – SHORT HISTORY AND EFFORTS TO CURE 1.1.1. Historical notes 1.1.2. The “war” against cancer 1.2. PARADIGM AND CHALLENGES OF ONCOTHERAPIES 1.3. LIMITATIONS OF ONCOTHERAPIES – QUEST FOR STEPS FORWARD 1.3.1. Medical challenge of oncotherapies 1.3.2. Ethical challenge of oncotherapies 1.3.3. Evaluation challenge of the results 2. HYPERTHERMIA RESULTS AND CHALLENGES 2.1. HYPERTHERMIA APPROACH 2.1.1. Definition of hyperthermia in oncology 2.1.2. Basic concepts of oncological hyperthermia 2.1.3. Technical variations of hyperthermia in oncology 2.2. EFFECTS OF HYPERTHERMIA 2.2.1. Higher baseline temperature 2.2.2. Vascular changes 2.2.3. Cellular membrane changes 2.2.4. Lactic acid formation 2.2.5. ATP depletion 2.2.6. Altered DNA replication 2.2.7. Enhanced immune reaction 2.2.8. Pain reduction 2.2.9. Selective gain of the heat-resistance 2.3. CLINICAL ONCOLOGICAL HYPERTHERMIA 2.3.1. Local and whole-body heating 2.3.2. Hyperthemia as a complementary method 2.4. HYPERTHERMIA SUCCESSES 2.4.1. Brain tumor treatments by hyperthermia 2.4.2. Pancreas tumor treatment by hyperthermia 2.4.3. Lung and bronchus 2.4.4. Hepatocellular carcinoma and metastatic tumors of liver 2.4.5. Colo-rectal tumors 2.4.6. Esophagus 2.4.7. Head and neck localizations 2.4.8. Gastric tumors 2.4.9. Breast tumors 2.4.10. Other localizations treated by hyperthermia 2.5. HYPERTHERMIA CHALLENGES IN ONCOLOGY 2.5.1. Challenge of selection and focus 2.5.2. Challenge of temperature 2.5.3. Medical challenges of hyperthermia in oncology 2.5.4. Challenge on quality control and dosimetry of hyperthermia 2.5.5. What we expect? 2.5.6. Possible solution: oncothermia 3. THERMO-BIO-PHYSICS 3.1. FACTORS OF PHYSIOLOGY HEATING 3.2. BIOTHERMODYNAMICS 3.2.1. Energy, heat and temperature 3.2.2. Energy of the chemical bonds and reactions 3.2.3. Energy sources and driving forces 3.2.4. Energy and structure 3.2.5. Energetics of malignant cells 3.2.6. “Non-thermal” effects – thermodynamial approach 3.3. BIOELECTRODYNAMICS 3.3.1. Basic interactions 3.3.2. The bioimpedance 3.3.3. “Nonthermal effects” – electrodynamical appraoch 3.3.4. “Non-thermal effects” – approach of electric currents 3.3.5. Membrane effects 3.3.6. Stochastic processes 3.3.7. Noises and signals 3.3.8. Resonances 3.3.9. Modulation-demodulation 3.3.10. Special field-effects of bio-systems 4. ONCOTHERMIA – NEW KIND OF ONCOLOGIC HYPERTHERMIA 4.1. ONCOTHERMIA CHARACTERISTICS 4.1.1. Electro Cancer Therapy (ECT) 4.1.2. Concept of oncothermia 4.1.3. Pennes equation revised 4.1.4. Thermal limit problem 4.1.5. Energy-transfer through the body surface 4.1.6. Penetration depth 4.1.7. Arrangement of electrodes 4.1.8. Far from equilibrium 4.1.9. Energy intake and temperature 4.1.10. Macroscopic focusing on the tumor 4.1.11. Heating the extracellular electrolyte 4.1.12. Temperature gradient and heat-flow on the membrane 4.1.13. Changes of the membrane potential 4.1.14. Membrane damage by constrained ion-currents 4.1.15. Effect on cell-cell connections 4.1.16. Oncotherm comparison 4.2. ONCOTHERMIA TREATMENT GUIDELINES 4.2.1. Treatment planning 4.2.2. Treatment consensus 4.3. COMPLEMENTARY APPLICATIONS 4.3.1. Complementary to radiotherapy 4.3.2. Complementary to chemotherapy 4.3.3. Clinical toxicity, safety 4.4. ONCOTHERMIA CASE REPORTS 4.4.1. Near eye treatments 4.4.2. Brain cases 4.4.3. Gynecology cases 4.4.4. Gastrointestinal cases 4.4.5. Pulmonary cases 4.4.6. Other cases 4.5. EVALUATION OF ONCOTHERMIA STUDIES 4.5.1. Evaluation conditions 4.5.2. Evaluation methods 4.6. GENERAL OVERVIEW ON A LARGE PATIENT’S POOL 4.7. BRAIN STUDIES 4.7.1. Brain safety study (Phase I) 4.7.2. Brain efficacy study (Phase II) 4.7.3. Hungarian brain glioma study 4.7.4. Small prospective, double arm brain glioma study 4.7.5. Study of brain gliomas with local clinical responses 4.7.6. Brain glioma study with relapses 4.7.7. Bicentral brain glioma study 4.7.8. Oncothermia for heavy pre-treated & relapsed brain gliomas 4.7.9. Study of metastatic brain tumors 4.7.10. Comparison of oncothermia brain studies 4.8. PANCREAS STUDIES 4.8.1. Pancreas efficacy study I. 4.8.2. Pancreas efficacy study II. (HTT) 4.8.3. Additional historical control to HTT pancreas study 4.8.4. Comparison of pancreas efficacy studies I. & II. 4.8.5. Pancreas efficacy study III. 4.8.6. Pancreas efficacy study IV. 4.8.7. Other oncothermia pancreas studies and their comparison 4.9. LUNG STUDIES 4.9.1. Oncothermia lung study I. 4.9.2. Oncothermia lung study II. 4.9.3. Meta-analysis of oncothermia lung studies 4.9.4. Compare to historical control 4.10. LIVER STUDIES 4.10.1. Study of liver metastases colorectal origine 4.10.2. Study of advanced liver metastases colorectal origine II. 4.10.3. Comparison study of treatment lines of colorectal liver metastases 4.10.4. Study of platinum derivatives with oncothermia for liver metastases from colorectal origine 4.10.5. Study of liver metastases rectal origine 4.10.6. Study of liver metastases various origine 4.10.7. Study of far advanced liver metastases various origines. Comparison of complementary therapies 4.11. COMPARISON OF STUDIES OF LIVER METASTASES 4.12. GYNECOLOGICAL (PELVIC) CANCER STUDY 4.12.1. Ovary study 4.12.2. Uterine corpus cancer 4.12.3. Uterine cervix 4.12.4. Comparison of oncothermia in pelvic gynecology 4.13. BREAST STUDY 4.14. ESOPHAGUS STUDY 4.14.1. Esophagus study I. 4.14.2. Esophagus study II. 4.15. STOMACH STUDY 4.16. COLO-RECTAL STUDIES 4.16.1. Preoperative oncothermia for rectum carcinoma 4.16.2. Colorectal carcinoma study 4.17. BONE STUDIES 4.17.1. Refractory bone metastases complementary to radiotherapy 4.17.2. Advanced bone metastases monotherapy 4.17.3. Osteosarcoma study 4.18. KIDNEY STUDY 4.19. HEAD AND NECK STUDY 4.20. URINARY BLADDER MALIGNANCIES 4.21. SOFT-TISSUE MALIGNANCIES 4.22. PROSTATE STUDY 4.23. ONCOTHERMIA PERSPECTIVES APPENDIX 1 ENTROPY AND TEMPERATURE APPENDIX 2 THERMODYNAMICS – ONSAGER’S RELATION APPENDIX 3 SELF-SIMILARITY AND BIOSCALING APPENDIX 4 ENERGY SUPPLY BY DEMANDS APPENDIX 5 ONCOGENIC GROWTH APPENDIX 6 BASIC BIOELECTROMAGNETICS APPENDIX 7 BIOIMPEDANCE OF CELLS & TISSUES APPENDIX 8 BOUNDARY CONDITIONS APPENDIX 9 DIRECT CURRENT APPLICATIONS APPENDIX 10 DEVELOPMENT OF EDEMA APPENDIX 11 WARBURG-IMPEDANCE APPENDIX 12 CELL-MEMBRANE PERMEABILITY APPENDIX 13 STOCHASTIC PROCESSES – PINK-NOISE APPENDIX 14 AUTOCORRELATION APPENDIX 15 DISSIPATIVE SYSTEMS APPENDIX 16 STOCHASTIC RESONANCE APPENDIX 17 RESONANCE OF ENZYMATIC REACTIONS APPENDIX 18 DEMODULATION BY STOCHASTIC RESONANCE APPENDIX 19 NON-LINEAR EFFECTS OF ENERGY-FLOW APPENDIX 20 PRINCIPLE OF MINIMAL ENERGY-DISPERSION APPENDIX 21 CHARGE-INHOMOGENETIES APPENDIX 22 PENNES’ EQUATION APPENDIX 23 PENNES’ EQUATION IS REVISED APPENDIX 24 SELF-FOCUSING APPENDIX 25 DYNAMISM OF TEMPERATURE ON THE MEMBRANE APPENDIX 26 CHANGES OF THE MEMBRANE-POTENTIAL APPENDIX 27 MEMBRANE DAMAGE BY INCREASING PRESSURE APPENDIX 28 DYNAMICS OF ADHERENT BONDS APPENDIX 29 MODULATION EFFECT APPENDIX 30 COMPONENTS OF CELL-DESTRUCTION APPENDIX 31 EXPERIMENTAL CONDITIONS IN VITRO APPENDIX 32 EXPERIMENTAL CONDITIONS IN VIVO APPENDIX 33 CONSIDERATIONS FOR EXPERIMENTAL SETUP IN VIVO APPENDIX 34 VALIDATION OF MORPHOLOGIC EVALUATION APPENDIX 35 EVALUATION OF SURVIVAL STUDY WITH SINGLE ARM 5. ACKNOWLEDGEMENT 6. REFERENCES

    1 in stock

    £170.99

  • Living in the Shadow of Death: A Rabbi Copes with

    Urim Publications Living in the Shadow of Death: A Rabbi Copes with

    Book SynopsisA heartfelt account of how Rabbi Weinblatt confronts cancer after receiving this devastating diagnosis, this memoir traces his journey from beginning to end. It deals with his emotions, fears, and treatment and offers comfort, encouragement, and inspiration from a Jewish perspective. Using humor and coupling it with the wisdom of Jewish and Biblical sources as reflected in his sermons and other communications and writings, his words are a vehicle for sharing his experience and insights as he battles this disease. As a comforter to others, as well as a recipient of comfort, support, and love from family, friends, and members of his congregation, this book is also a valuable tool for clergy and health care professionals who interact with and counsel individuals in similar situations.Trade Review"Candid, informative, and ultimately inspiring, Living in the Shadow of Death: A Rabbi Copes with Cancer is a compelling read from beginning to end. Rabbi Stuart G. Weinblatt . . . has done a tremendous service to others having to face similar threats of terminal illness. Living in the Shadow of Death is very highly recommended for personal reading lists, as well as community and academic library collections." Taylor, Midwest Book Review

    £20.95

  • £11.35

  • £14.41

  • Screening and Risk Reduction Strategies for

    Springer Verlag, Singapore Screening and Risk Reduction Strategies for

    1 in stock

    Book SynopsisThis book provides readers with the most up-to-date practical information on breast cancer screening. Since breast cancers are highly heterogeneous, time to clinical onset from the initial carcinogenesis differs diversely between cancers. Pathological germline variants and driver mutations cause a high lifetime risk of breast cancer. The lifetime risks are various according to what genes are pathologically dysfunctional. Integrated omics and imaging technologies have established varying tumour characteristics. Thus, this book suggests that a more individualised scheme is required to improve breast cancer screening. A key aim is to demonstrate how multiple diagnostic imaging modalities such as mammography, ultrasonography, MRI, PET and dbPET improve breast cancer screening accuracy. Mammography screening alone may have a limited impact on breast cancer risk prediction. These issues are crucial to discuss. Clinical experts recommend that new modalities be incorporated for women with dense breasts, like ultrasonography, dynamic mammography, MRI and maybe breast-dedicated PET. Topics on these modalities are going to be summarized in this book. An in-depth review of these modalities is summarised in this book. In addition, new diagnostic modalities, including risk assessment tools, multi-cancer early detection tests using liquid biopsy, the role of protein biomarkers in breast cancer risk screening, challenges, and hopes for future advances, are also covered in this book.Table of Contents1. Introduction of the whole issue.- 2. Breast cancer epidemiology: incidence, risks and subtype.- 3. Personalized genetic breast cancer risk estimation with polygenic risk scores.- 4. Mathematical model forassessing breast cancer risk.- 5. Cost-effectiveness Analysis of multigene testing.- 6. Hereditary breast cancer: Its biology, subtype and clinical phenotype.- 7. Surgical risk reduction of breast cancer.- 8. Medical risk reduction of breast cancer.- 9. Screening for breast cancer with mammography.- 10. Breast cancer screening: Weighing the benefits and harms.- 11. Breast cancer screening according to individual risk.- 12. MRI: Detection of noninvasive diseases.- 13. Significance of MRI for women having dense breasts .- 14. Ultrasound: screening of breast cancer.- 15. Detection of breast cancer by PET.- 16. Radiowave mammography.- 17. Photoacoustic imaging of breast cancer.

    1 in stock

    £119.99

  • Pathogenesis and Treatment of Leukemia

    Springer Verlag, Singapore Pathogenesis and Treatment of Leukemia

    Out of stock

    Book SynopsisThis book covers a comprehensive update on acute and chronic leukemia. In 54 chapters, authors introduce research progress and clinical trials of acute myeloid leukaemia (AML), acute promyelocytic leukaemia (APL), acute lymphoblastic leukaemia (ALL), myelodysplastic syndrome (MDS), myeloproliferative neoplasm (MPN) and chronic myeloid leukemia (CML). The last decade has seen the integration of genetic and clinical information to determine the prognosis and treatment strategies. This book provides practitioners, researchers and graduate students of Hematology and Hematopathology a comprehensive update on the pathobiology, genomics, classification, diagnosis, monitoring, prognostication and therapy of both acute and chronic leukemias.Table of ContentsChapter 1 Basic haematopoiesis and leukemia stem cells Chapter 2 Modern classification of acute and chronic leukemias: integrating biology, clinicopathologic features and genomics Chapter 3 Molecular techniques in the diagnosis and monitoring of acute and chronic leukemias Chapter 4 Flow cytometric techniques in the diagnosis and monitoring of acute leukemias Chapter 5 Genomic Landscape and Risk Stratification of Acute Myeloid Leukemia Chapter 6 Frontline management of acute myeloid leukaemia eligible for intensive chemotherapy Chapter 7 Frontline management of elderly acute myeloid leukemia ineligible for intensive treatment Chapter 8 Management of Acute Myeloid Leukemia with Myelodysplasia-Related Changes and Therapy-Related Acute Myeloid Leukemia Chapter 9 Management of relapsed or refractory AML Chapter 10 The Role of BCL-2 / MCL-1 targeting in Acute Myeloid Leukemia Chapter 11 Role of IDH1/IDH2 inhibitors in AML Chapter 12 Next-generation FLT3 inhibitors for the treatment of FLT3-positive AML Chapter 13 Allogeneic hematopoietic stem cell transplantation for AML Chapter 14 Maintenance therapy following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia Chapter 15 Immunotherapeutic targeting of AML Chapter 16 In the pipeline – Emerging therapy for acute myeloid leukaemia Chapter 17 Frontline management of acute promyelocytic leukemia Chapter 18 Management of relapsed acute promyelocyticleukemia and the role of hematopoietic stem cell transplantation Chapter 19 Genomic Landscape of Acute Lymphoblastic Leukaemia (ALL) – Insights to Leukaemogenesis, Prognostications and Treatment Chapter 20 Management of adolescent and young adults with Acute Lymphoblastic Leukaemia Chapter 21 Management of older patients with acute lymphoblastic leukemia Chapter 22 Management of Philadelphia Chromosome-positive Acute Lymphoblastic Leukaemia Chapter 23 Management of Philadelphia Chromosome-like Acute Lymphoblastic Leukemia (Ph-like ALL) Chapter 24 Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia Chapter 25 Immunotherapy for ALL Chapter 26 In the Pipeline - Emerging therapy for ALL Chapter 27 Inherited/genetic predisposition to MDS and AML Chapter 28 Clonal hematopoiesis and its functional implications in MDS/AML Chapter 29 Therapy-related MDS/AML and the role of environmental factors Chapter 30 Prognostic indicators in MDS and CMML Chapter 31 Treatment algorithm of myelodysplastic syndromes Chapter 32 Treatment algorithm of CMML and other uncommon MDS/MPN subtypes Chapter 33 Novel strategies to manage cytopenia in low-risk MDS Chapter 34 Allogeneic hematopoietic stem cell transplantation for MDS and CMML: when and how? Chapter 35 In the Pipeline - Emerging therapy for MDS and MDS/MPN Chapter 36 Molecular landscape and personalized prognostic prediction of MPNs Chapter 37 Treatment algorithm of polycythemia Vera Chapter 38 Treatment algorithm of essential thrombocythemia Chapter 39 Prognostic models for primary and secondary myelofibrosis Chapter 40 Treatment algorithm for primary and secondary myelofibrosis Chapter 41 Diagnosis and management of prefibrotic primary myelofibrosis (pre-PMF) Chapter 42 Interferons In myeloproliferative neoplasms Chapter 43 JAK inhibitors for the management of myeloproliferative neoplasms Chapter 44 Allogeneic hematopoietic stem cell transplantation for myelofibrosis – when and how? Chapter 45 Thrombosis and myeloproliferative neoplasms Chapter 46 Eosinophilic disorders and systemic mastocytosis Chapter 47 In the Pipeline - Emerging therapy for classical Ph-negative MPNs Chapter 48 "Current guidelines and treatment algorithm of chronic myeloid leukaemia" Chapter 49 Treatment-free remission in chronic myeloid leukemia Chapter 50 Treatment options in CML resistant or intolerant to second-generation tyrosine kinase inhibitors Chapter 51 Allogeneic hematopoietic cell transplantation in CML: when and how? Chapter 52 In the Pipeline - Emerging therapy for CML

    Out of stock

    £999.99

  • CRC Press Stell Marans Textbook of Head and Neck Surgery

    Out of stock

    Book SynopsisFirst written by Philip Stell and Arnold Maran in 1972, Stell & Maran's Textbook of Head and Neck Surgery and Oncology has been revised in both content and approach over the years to reflect the enormous progress made in the area. Now in its fifth edition, the book remains a key textbook for trainees in otolaryngology and head and neck surgery.Written with a strong multidisciplinary approach, the book has expanded considerably to include the expertise of international editors and contributing authors from a wide variety of backgrounds, including ENT, radiotherapy, plastic surgery, and maxillofacial surgery.Key Features: An international team of editors and contributors from a variety of different specialties Thoroughly updated to include recent advances in molecular biology and diagnostic imaging A greatly expanded section on reconstruction to reflect the importance of this area An improved balanTrade Review "It is a bigger and better book than its predecessor... the entire book is well organized ... plenty of colourful pictures, diagrams, tables, summary, and key point boxes."—The Journal of Laryngology & Otology"The fifth edition has been worth the wait and shall remain an essential first text and reference book for trainee head and neck surgeons the world over. It is clearly written and is an excellent resource for every trainee's library."—ENT News " … beautifully illustrated throughout with colour clinical photographs, excellent line diagrams, and appropriate imaging. … The section on non surgical treatments such as chemo and radiotherapy and biological targeting was particularly good and relatively easy to read!"—P.A. Brennan, Queen Alexandra Hospital, Portsmouth, UK, British Journal of Oral and Maxillofacial Surgery Table of Contents Introduction to Head and Neck Surgery. Benign Disease. Endocrine Disease. Malignant Disease. Reconstruction. Directions For Future Research and Developments In Head and Neck Cancer Surgery.

    Out of stock

    £266.00

  • Brown Books Publishing Group Id Rather Do Chemo Than Clean Out the Garage

    3 in stock

    Book Synopsis

    3 in stock

    £14.90

  • Pocket Guide to Oncologic Emergencies

    Cambridge University Press Pocket Guide to Oncologic Emergencies

    Out of stock

    Book SynopsisA concise and practical handbook for diagnosing, managing, and treating the myriad of oncologic emergencies that are often presented by cancer patients. The book will provide easy access to the most up-to-date information to assist healthcare professionals working in acute care settings such as the emergency department or urgent care.Trade Review'Dr. Monica Wattana has assembled 'must have' information to diagnose and treat a wide variety of urgent and emergent conditions experienced by the cancer patient, providing key information presented in an easily digestible format to assist the busy clinician. Featuring 'clinical pearls' and up-to-date references in each chapter, this text provides concise reviews of clinically important cancer emergencies with which the general practitioner may be less familiar. Easy access to the numerous grading and risk-stratifying schemes involved in cancer care, alongside their acronyms and together in one source, will save users valuable time. This is a welcome aid for medical students, residents, nurses, and midlevel practitioners facing questions on ward rounds or in certification exams, offering us the essential guidance to provide superior care to the growing number of patients with cancer emergencies.' Knox H. Todd, M.D., M.P.H.; Editor-in-Chief, Emergency Cancer Care; Editor, Oncologic Emergency Medicine: Principles and Practice, 2nd EditionTable of ContentsIntroduction 1. Cancer overview: Part I. Anti-cancer Treatment Overview: 2. Chemotherapy; 3. Hematopoietic stem cell transplant; 4. Hormone therapy; 5. Immunotherapy; 6. Radiation therapy; 7. Targeted cell therapy; Part II. Pain and Palliative Care in the Emergency Department: 8. Acute pain management; 9. Opiate equianalgesic conversion; 10. Patient controlled analgesia pump; 11. Communication tips for delivering bad news; 12. End of life symptom management; Part III. Systems Based Overview of Cancer Complications: 13. Overview of Cardiovascular Disease in Cancer Patients; Chapter I. Cardiovascular: 14. Cancer treatment induced arrhythmia; 15. Acute coronary syndrome; 16. Blood transfusion complications; 17. Carotid blowout syndrome; 18. Disseminated intravascular coagulation; 19. Heart failure; 20. Hyperviscosity syndrome; 21. Pericardial effusion and tamponade; 22. Pericarditis; 23. SVC syndrome; 24. Venous thromboembolism management; Chapter II. Gastrointestinal: 25. Constipation management; 26. Cancer related diarrhea; 27. Chemotherapy induced nausea and vomiting; 28. Feeding tube complications; 29. Malignant bowel obstruction; 30. Malignant intestinal perforation; 31. Mesenteric bowel ischemia; 32. Mucositis; 33. Neutropenic enterocolitis (Typhlitis); 34. Radiation enteritis; 35. Sinusoidal obstructive syndrome; Chaper III. Genitourinary: 36. Gynecological oncology surgical complications; 37. Hemorrhagic cystitis; 38. Hypercalcemia; 39. Hyponatremia; 40. Obstructive uropathy; 41. Troubleshooting percutaneous nephrostomy tubes; Chapter IV. Integumentary: 42. Chemotherapy extravasation management; Chapter V. Lymphatic: 43. CART-Cell toxicity; 44. Checkpoint inhibitor immune-related adverse events; 45. Differentiation syndrome in acute leukemias; 46. GVHD; 47. Hyperleukocytosis and leukostasis; 48. Neutropenic fever; 49. Tumor lysis syndrome; Chapter VI. Nervous: 50. Approach to cancer patient with altered mental status; 51. Delirium symptom management; 52. Depression in cancer patients; 53. Elevated intracranial pressure; 54. Intracranial hemorrhage; 55. Leptomeningeal disease; 56. Malignant spinal cord compression and cauda equina syndrome; 57. Paraneoplastic syndromes; 58. Seizure management; 59. Stroke management in cancer patients; Chapter VII. Respiratory: 60. Cancer treatment induced interstitial lung disease; 61. Hemoptysis; 62. Hiccups; 63. Laryngectomy troubleshooting; 64. Malignant central airway obstruction; 65. Malignant pleural effusion; 66. Tracheostomy troubleshooting; Index.

    Out of stock

    £999.99

  • Breast Care Certification Review

    John Wiley & Sons Breast Care Certification Review

    1 in stock

    Book Synopsis

    1 in stock

    £71.10

  • Cancer and Occupational Therapy: Enabling

    American Occupational Therapy Cancer and Occupational Therapy: Enabling

    Out of stock

    Book SynopsisCancer and its treatment create challenges, disruptions, and obstacles to full participation in life roles and everyday activities. The growing population of cancer survivors across the lifespan presents an immediate challenge and opportunity for occupational therapy practitioners to provide occupation-focused, evidence-based interventions that support participation. As availability of rehabilitation services for cancer increases, occupational therapy practitioners must be prepared to meet the needs of this population. Cancer and Occupational Therapy equips clinicians to meet clients’ needs across the cancer care continuum, from diagnosis to treatment to survivorship or end of life.Highlights include: Part I. Understanding Cancer and Cancer Rehabilitation—cancer demographics and trends, cancer treatment approaches, applying the Occupational Therapy Practice Framework with cancer survivors. Part II. Impact of Common Forms of Cancer Across the Lifespan—special considerations for children, adolescents and young adults, adults, older adults with cancer. Part III. Cancer Care Continuum and Cancer Rehabilitation—primary and secondary prevention, acute and medically complex settings, prehabilitation, acute inpatient rehabilitation, survivorship, palliative care and hospice, home health and the community. Part IV. Sequelae of Cancer and Interventions Across the Lifespan—cancer-related fatigue, pain, and cognitive impairment; lymphedema; chemotherapy-induced peripheral neuropathy. Part V. Cancer and Participation in Occupation Across the Lifespan—psychosocial issues, ADLs and IADLs, rest and sleep, play and leisure, education, work, social participation, caregiving. Aligned with the Occupational Therapy Practice Framework, this important new text includes case examples, key terms and concepts, and practical guidance to help survivors fully participate in valued occupations at all points in the cancer experience.

    Out of stock

    £126.90

  • Probably Someday Cancer: Genetic Risk and

    University of North Texas Press,U.S. Probably Someday Cancer: Genetic Risk and

    Out of stock

    Book SynopsisAfter learning that she inherited a BRCA2 genetic mutation that put her at high risk for breast and ovarian cancer, Kim Horner's doctors urged her to consider having a double mastectomy. But how do you decide whether to have a surgery to remove your breasts to reduce your risk for a disease you don't have and may never get? Horner shares her struggle to answer that question in Probably Someday Cancer. The mother of a one-year-old boy, she wanted to do whatever would give her the best odds of being around for her son and protect her from breast cancer, which killed her grandmother and great-grandmother in their 40s. Which would give her the best chance at a long healthy life: a double mastectomy or frequent screenings to try to catch any cancer early? The answers weren't that simple. Based on extensive research, interviews, and personal experience, Horner writes about how and why she ultimately opted for a double mastectomy—the same decision actress Angelina Jolie made for a similar genetic mutation—and the surprising diagnosis that followed. The book explores difficult truths that get overshadowed by upbeat messages about early detection and survivorship—the fact that screenings can miss cancers and that even early-stage breast cancers can spread and become fatal. Probably Someday Cancer is about the author's efforts to push past her fear and anxiety. This book can help anyone facing hereditary risk of breast and ovarian cancer feel less alone and make informed decisions to protect their health and end the devastation that hereditary cancer has caused for generations in so many families.Trade ReviewWith the ease and comfort of a trusted friend, Kim Horner expertly takes you through her personal journey, sharing her thoughts and evolution around the difficult decisions that she had to make about genetic counseling, testing, and risk management. This is a moving and candid memoir."" - Sue Friedman, Executive Director of FORCE

    Out of stock

    £999.99

© 2026 Book Curl

    • American Express
    • Apple Pay
    • Diners Club
    • Discover
    • Google Pay
    • Maestro
    • Mastercard
    • PayPal
    • Shop Pay
    • Union Pay
    • Visa

    Login

    Forgot your password?

    Don't have an account yet?
    Create account